tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

AMGN Stock Latest News

Amgen’s Phase 2a Study on Autoimmune Diseases: A Potential Game Changer?
Company AnnouncementsAmgen’s Phase 2a Study on Autoimmune Diseases: A Potential Game Changer?
1d ago
AMGN
Amgen’s Xaluritamig Study: A New Hope for Prostate Cancer Treatment
PremiumCompany Announcements
Amgen’s Xaluritamig Study: A New Hope for Prostate Cancer Treatment
1d ago
AMGN
Amgen’s New Obesity Drug Study: A Potential Game-Changer?
PremiumCompany Announcements
Amgen’s New Obesity Drug Study: A Potential Game-Changer?
1d ago
AMGN
Amgen’s CodeBreaK 202: A New Front-Line Therapy for Advanced Lung Cancer?
PremiumCompany Announcements
Amgen’s CodeBreaK 202: A New Front-Line Therapy for Advanced Lung Cancer?
1d ago
AMGN
Amgen’s Tarlatamab Study: A Potential Game-Changer in Lung Cancer Treatment
PremiumCompany Announcements
Amgen’s Tarlatamab Study: A Potential Game-Changer in Lung Cancer Treatment
1d ago
AMGN
AstraZeneca and Amgen’s COPD Study: A Potential Game-Changer?
PremiumCompany AnnouncementsAstraZeneca and Amgen’s COPD Study: A Potential Game-Changer?
2d ago
AZN
AMGN
AstraZeneca and Amgen’s Tezepelumab Study: A Potential Game-Changer for COPD Treatment
Premium
Company Announcements
AstraZeneca and Amgen’s Tezepelumab Study: A Potential Game-Changer for COPD Treatment
2d ago
AZN
AMGN
Amgen’s Promising Study on Romosozumab: A Potential Game-Changer in Osteogenesis Imperfecta Treatment
Premium
Company Announcements
Amgen’s Promising Study on Romosozumab: A Potential Game-Changer in Osteogenesis Imperfecta Treatment
2d ago
AMGN
Amgen’s Prolia Study in China: A Potential Game-Changer for Male Osteoporosis Treatment
PremiumCompany Announcements
Amgen’s Prolia Study in China: A Potential Game-Changer for Male Osteoporosis Treatment
2d ago
AMGN
Amgen’s New Study on ABP 692: A Potential Game-Changer in MS Treatment?
PremiumCompany Announcements
Amgen’s New Study on ABP 692: A Potential Game-Changer in MS Treatment?
2d ago
AMGN
Amgen’s Romiplostim Study: A Potential Game-Changer for Cancer Treatment
PremiumCompany Announcements
Amgen’s Romiplostim Study: A Potential Game-Changer for Cancer Treatment
2d ago
AMGN
Amgen’s AMG 691: A Promising Phase 1 Study for Asthma Treatment
PremiumCompany Announcements
Amgen’s AMG 691: A Promising Phase 1 Study for Asthma Treatment
2d ago
AMGN
Amgen’s Promising Phase 3 Study on Weight Loss Drug for Diabetes
PremiumCompany AnnouncementsAmgen’s Promising Phase 3 Study on Weight Loss Drug for Diabetes
2d ago
AMGN
Amgen’s Promising Extension Study on Dazodalibep for Sjögren’s Syndrome
Premium
Company Announcements
Amgen’s Promising Extension Study on Dazodalibep for Sjögren’s Syndrome
2d ago
AMGN
Amgen’s Rocatinlimab Study: A Potential Game-Changer in Asthma Treatment
Premium
Company Announcements
Amgen’s Rocatinlimab Study: A Potential Game-Changer in Asthma Treatment
2d ago
AMGN
Amgen’s Prolia® Study: A Potential Game-Changer for Osteoporosis Treatment
PremiumCompany Announcements
Amgen’s Prolia® Study: A Potential Game-Changer for Osteoporosis Treatment
2d ago
AMGN
Amgen’s Innovative Approach to Treating Advanced Thoracic Tumors: A Closer Look at the AMG 193 Study
PremiumCompany Announcements
Amgen’s Innovative Approach to Treating Advanced Thoracic Tumors: A Closer Look at the AMG 193 Study
2d ago
AMGN
Amgen’s New Study on Metastatic Colorectal Cancer: A Potential Game Changer?
PremiumCompany Announcements
Amgen’s New Study on Metastatic Colorectal Cancer: A Potential Game Changer?
2d ago
AMGN
Amgen’s Latest Study: A New Hope for Lung Cancer Treatment?
PremiumCompany Announcements
Amgen’s Latest Study: A New Hope for Lung Cancer Treatment?
2d ago
AMGN
Amgen’s Phase 3 Trial on Teprotumumab: A Potential Game-Changer for Thyroid Eye Disease
PremiumCompany AnnouncementsAmgen’s Phase 3 Trial on Teprotumumab: A Potential Game-Changer for Thyroid Eye Disease
2d ago
AMGN
Amgen’s Tarlatamab Study: A New Hope for Small Cell Lung Cancer
Premium
Company Announcements
Amgen’s Tarlatamab Study: A New Hope for Small Cell Lung Cancer
2d ago
AMGN
Amgen’s Golden Gate Study: A New Hope in Leukemia Treatment?
Premium
Company Announcements
Amgen’s Golden Gate Study: A New Hope in Leukemia Treatment?
2d ago
AMGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >